Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 2/3 1

Status

Completed 28Terminated 10Unknown 4Withdrawn 1Suspended 1

Sponsor Class

INDUSTRY 2OTHER_GOV 1OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 2Hyperplasia 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Calcitriol × Clear all
NCT00926315 2012-11-01

Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation

University of Sao Paulo General Hospital

Phase NA Unknown
60 enrolled
Breast

Breast Neoplasms, Hyperplasia

NCT01039181 2009-12-24

Calcitriol in Advanced Intrahepatic Cholangiocarcinoma

National Science and Technology Development Agency, Thailand

Phase 2 Unknown
28 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT00043576 2009-03-12

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Novacea

Phase 2/3 Unknown
250 enrolled
Genitourinary

Prostatic Neoplasms

NCT00285675 2006-05-31

Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004

Novacea

Phase 2 Unknown
25 enrolled
GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡